George Kemble - 12 Jun 2026 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Reporting relationship: Director
Issuer ticker: SGMT
Reported as of: 12 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 16:20:22 UTC
Prior SEC filing: 21 Nov 2025
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Rozek, Attorney-in-Fact

Key filing fact

George Kemble filed Form 4 for Sagimet Biosciences Inc. (SGMT) on 15 Jun 2026.

Key facts

This page summarizes George Kemble's Form 4 filing for Sagimet Biosciences Inc. (SGMT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2026, 16:20.

Change

Previous filing in this sequence was filed on 21 Nov 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001858176 Primary reporting owner

Kemble George

Relationship: Director
Address: SAGIMET BIOSCIENCES INC., 155 BOVET ROAD, SUITE 303, SAN MATEO
Signature: /s/ Elizabeth Rozek, Attorney-in-Fact
Signature date: 15 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SGMT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +39,567
Change %
Price: $0.000000^*
Shares after: 39,567
Date: 12 Jun 2026
Ownership: Direct
Underlying class: Series A Common Stock
Underlying amount: 39,567
Exercise price: $6.48
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date.